Abbott Announces Recall of Infant Formula Over Defective Caps

MONDAY, Oct. 17, 2022 (HealthDay News) — Abbott Inc. has announced that it is again recalling some of its infant formula products, though the company said this latest recall is small and should not significantly impact nationwide supply.

The recall was triggered by the fact that some bottles may have defective caps that could cause the product to spoil, which could lead to diarrhea and vomiting if consumed.

“This recall equates to less than one day’s worth of the total number of ounces of infant formula fed in the U.S. and is not expected to impact the overall U.S. infant supply,” Abbott said in a statement released Friday.

The company is recalling specific 2-oz bottles of Ready-to-Feed liquid products for infants and children made at its Ohio plant under the brands Similac Pro-Total Comfort, Similac 360 Total Care, Similac 360 Total Care Sensitive, Similac Special Care 24, Similac Stage 1, Similac NeoSure, Similac Water (Sterilized), and Pedialyte Electrolyte Solution.

Abbott advised customers to not use any recalled formula and to visit similacrecall.com to see a list of the lot numbers affected by the recall. Most of the recalled products were sent to hospitals, doctors’ offices, and retailers in the United States, including Puerto Rico. An additional lot was sent to Barbados, Bermuda, Colombia, the Dominican Republic, Haiti, Jamaica, St. Croix, and St. Thomas. Two more lots were distributed to Canada, Curacao, Panama, and Trinidad and Tobago, the company said.

The company is continuing to produce the product on a different production line for hospitals and health care providers. It has also increased production at other plants. The formula is still for sale at retailers in other product sizes.